Pyxis Oncology annual operating expenses
2020
2021
2022
2023
2024
2025
Pyxis Oncology Operating Expenses Growth & History (PYXS)
Pyxis Oncology's operating expenses was $95.9M for fiscal 2025.
View full Pyxis Oncology company overviewPyxis Oncology annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $95.9M | −$9.2M | −8.79% |
| 2024 | 2024-12-31 | $105.1M | $22.9M | +27.90% |
| 2023 | 2023-12-31 | $82.2M | −$41.3M | −33.43% |
| 2022 | 2022-12-31 | $123.5M | $53.8M | +77.12% |
| 2021 | 2021-12-31 | $69.7M | $56.8M | +440.69% |
| 2020 | 2020-12-31 | $12.9M | — | — |
Pyxis Oncology quarterly operating expenses
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $26.0M | $3.4M | +15.15% |
| Q1 2026 | 2026-03-31 | $24.4M | $1.4M | +6.31% |
| Q4 2025 | 2025-12-31 | $26.9M | −$13.1M | −32.75% |
| Q3 2025 | 2025-09-30 | $23.5M | −$293,000 | −1.23% |
| Q2 2025 | 2025-06-30 | $22.6M | $2.5M | +12.67% |
| Q1 2025 | 2025-03-31 | $22.9M | $1.6M | +7.70% |
| Q4 2024 | 2024-12-31 | $40.1M | $22.3M | +125.52% |
| Q3 2024 | 2024-09-30 | $23.8M | −$1.6M | −6.31% |
| Q2 2024 | 2024-06-30 | $20.0M | $1.9M | +10.55% |
| Q1 2024 | 2024-03-31 | $21.3M | $322,000 | +1.54% |
| Q4 2023 | 2023-12-31 | $17.8M | −$20.2M | −53.21% |
| Q3 2023 | 2023-09-30 | $25.4M | −$3.0M | −10.70% |
| Q2 2023 | 2023-06-30 | $18.1M | −$7.6M | −29.56% |
| Q1 2023 | 2023-03-31 | $21.0M | −$10.4M | −33.24% |
| Q4 2022 | 2022-12-31 | $38.0M | $21.5M | +131.18% |
| Q3 2022 | 2022-09-30 | $28.4M | $16.8M | +144.32% |
| Q2 2022 | 2022-06-30 | $25.7M | $19.8M | +333.02% |
| Q1 2022 | 2022-03-31 | $31.4M | −$4.3M | −12.15% |
| Q4 2021 | 2021-12-31 | $16.4M | — | — |
| Q3 2021 | 2021-09-30 | $11.6M | $8.4M | +264.07% |
| Q2 2021 | 2021-06-30 | $5.9M | — | — |
| Q1 2021 | 2021-03-31 | $35.7M | — | — |
| Q3 2020 | 2020-09-30 | $3.2M | — | — |
Pyxis Oncology operating expenses trends
Over the last five fiscal years, Pyxis Oncology's operating expenses increased from $12.9M to $95.9M, a change of $83.0M. The latest reported quarter, Q2 2026, shows $26.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pyxis Oncology source filings ↗